Latest Breaking News On - Laura tadvalkar - Page 1 : comparemela.com

Cidara Therapeutics Provides Corporate Update and Reports

Cidara Therapeutics Provides Corporate Update and Reports
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesDavid gollaherBrian ritchieJeffrey steinLaura tadvalkarTimothy fransonRyan spencerMichael fitzhughJames mersonCompany board of directorsCidara therapeutics incEuropean society of clinical microbiologyJanssen pharmaceuticals incBiotech value fundLifesci communications

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesJames mersonMichael fitzhughDavid gollaherTimothy fransonLaura tadvalkarRyan spencerJessica sagersBrian ritchieJeffrey steinJohnson companyJanssen pharmaceuticals incCidara therapeutics incLifesci communicationsSecurities exchange

Hyku Biosciences, Inc : Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

Hyku Biosciences, Inc : Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMilind deshpandeMatthias van woenselHyku biosciencesLaura tadvalkarKen hsuMark mulvihillFay evans martinMark foundation for cancer researchMark foundation emerging leader awardHyku biosciences inc viewUniversity of texas at austinHyku biosciences incNovartis venture fundUniversity of virginiaDroia ventures

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMark mulvihillMatthias van woenselKen hsuHyku biosciencesFay evans martinMilind deshpandeLaura tadvalkarUniversity of texas at austinNovartis venture fundUniversity of virginiaHyku biosciences incMark foundation emerging leader awardMark foundation for cancer researchDroia venturesMark foundation

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines .

United statesMark mulvihillKen hsuFay evans martinEisai innovationLaura tadvalkarMilind deshpandeHyku biosciencesMatthias van woenselMark foundation emerging leader awardHyku biosciences incUniversity of texas at austinNews networkNovartis venture fundMark foundation for cancer researchUniversity of virginia